AbbVie Announces Initiation of Phase 3 Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma
AbbVie announced on July 28, 2016, the initiation of a Phase 3 clinical trial to study the safety and efficacy of venetoclax in combination with bortezomib and [...]